Mesothelin-expressing advanced cancers

Clinical trials for Mesothelin-expressing advanced cancers explained in plain language.

Never miss a new study

Get alerted when new Mesothelin-expressing advanced cancers trials appear

Sign up with your email to follow new studies for Mesothelin-expressing advanced cancers, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Terminated 1

Experimental cancer drug ZW171 tested in 32 patients, but study stopped early

Disease control Stopped early

This early-phase study tested a new drug called ZW171 in 32 people with advanced ovarian, lung, or other cancers that have a protein called mesothelin. The main goals were to check the drug's safety and find the right dose. The study was terminated early, so results are limited.

Matched conditions: MESOTHELIN-EXPRESSING ADVANCED CANCERS

Phase 1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC

Mesothelin-expressing advanced cancers

Get alerted when new Mesothelin-expressing advanced cancers trials appear

Experimental cancer drug ZW171 tested in 32 patients, but study stopped early